M. Greene

发表

Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping.

B. Blumberg, O. Mcbride, G. Greene, 1995, Gene expression.

Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis.

R. Arceci, J. Crispino, S. Gurbuxani, 2003, Blood.

Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.

R. Arceci, M. McDevitt, J. Karp, 2003, Blood cells, molecules & diseases.

The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation

B M Raaka, H H Samuels, B. Raaka, 1995, Molecular and cellular biology.

Identification of midkine as a mediator for intercellular transfer of drug resistance

A. Rebbaa, B. Mirkin, Xin Zheng, 2005, Oncogene.

Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer

G. Raj, W. Tilley, T. Hickey, 2016, Science Advances.

Peroxisome proliferator-activated receptor gamma as a novel target in cancer therapy: binding and activation by an aromatic fatty acid with clinical antitumor activity.

D. Samid, W. Shen, M. Greene, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Novel expression and function of peroxisome proliferator-activated receptor gamma (PPARgamma) in human neuroblastoma cells.

S. Han, J. Pitts, Randal K. Wada, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome

M. L. Beau, M. McDevitt, J. Karp, 2002, Nature Genetics.

Bcl-xL and Akt cooperate to promote leukemogenesis in vivo

C. Rudin, Robyn Karnauskas, D. Plas, 2003, Oncogene.

Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling

Henry W. Long, P. Rao, Raga Vadhi, 2017, Oncotarget.

Peroxisome Proliferator-activated Receptor g as a Novel Target in Cancer Therapy : Binding and Activation by an Aromatic Fatty Acid with Clinical Antitumor Activity 1

D. Samid, W. Shen, M. Greene, 2000 .

Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer

B. Komm, G. Greene, S. Fanning, 2021, Breast Cancer Research.

PPARgamma: observations in the hematopoietic system.

J. Pitts, M. McCarville, M. Greene, 2000, Prostaglandins & other lipid mediators.

Isolation and cloning of human peroxisome proliferator activated receptor gamma cDNA.

B. Blumberg, G. Greene, S. Nimer, 1997, Advances in experimental medicine and biology.

Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer

M. Lainé, M. Greene, J. D. Kurleto, 2024, Breast cancer research : BCR.